Abstract
Chronic benzodiazepine treatment can produce tolerance and changes in γ-aminobutyric acid (GABA)A receptors. To study the effect of treatment on a selected population of receptors, assays were performed using [3H]RY-80, which is selective for GABAA receptors with an α5 subunit. Rats were given a flurazepam treatment known to produce tolerance and down-regulation of benzodiazepine binding, or a diazepam treatment shown to produce tolerance but not receptor down-regulation. Quantitative receptor autoradiography using sagittal brain sections bound with [3H]RY-80 showed binding in areas known to express α5 mRNA. Brains from flurazepam-treated rats showed significantly decreased 1 nM [3H]RY-80 binding in hippocampal formation (e.g., 32% decrease in CA1) and superior colliculus, but not other areas. Using 5 nM [3H]RY-80 showed similar decreases in hippocampus. A corresponding 29% decrease inBmax but no change inKd was found with a filtration binding assay using hippocampal homogenates. Down-regulation of [3H]RY-80 binding had returned to control by 2 days after withdrawing flurazepam treatment. The magnitude of down-regulation of [3H]RY-80 binding suggested that GABAAreceptors with an α5 subunit may play a prominent role in the adaptive responses associated with benzodiazepine tolerance. Chronic diazepam treatment also resulted in decreased [3H]RY-80 binding. However, the regional selectivity was even more pronounced than in flurazepam-treated rats, and only the hippocampal CA1 region showed decreased binding (27%). This localized down-regulation persisted for several days after the end of diazepam treatment. These data indicate that synapses in the hippocampal CA1 region are particularly involved in the adaptive response to chronic benzodiazepine treatments.
Footnotes
-
Send reprint requests to: Dr. Howard C. Rosenberg, Department of Pharmacology and Therapeutics, Medical College of Ohio, 3035 Arlington Ave., Toledo, OH 43614-5804. E-mail: hrosenberg{at}mco.edu
-
↵1 This work was supported by research Grant RO1-DA02194 from the National Institute on Drug Abuse.
- Abbreviation:
- GABA
- γ-aminobutyric acid
- Received April 27, 2000.
- Accepted July 27, 2000.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|